SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany · Delayed Price · Currency is EUR 14.78
-0.10 (-0.67%)
At close: Feb 27, 2026
ETR:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 240.19M EUR in the quarter ending December 31, 2025, with 3.81% growth. This brings the company's revenue in the last twelve months to 995.03M, up 4.06% year-over-year. In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M with 3.04% growth.
Revenue (ttm)
995.03M
Revenue Growth
+4.06%
P/S Ratio
2.24
Revenue / Employee
206.05K
Employees
4,829
Market Cap
2.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 986.21M | 29.12M | 3.04% |
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.20B |
| Ottobock SE & Co. KGaA | 1.66B |